Trial
NCT02138786
Selinexor in Initial or Refractory and/or Relapsed Richter's Transformation
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Karyopharm Therapeutics Inc
Collaborators
—
Condition
Richter's Transformation
Intervention
selinexor
Why stopped
Lack of efficacy at time of interim analysis
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-01-26